Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 5.36
+0.26 (5.00%)
Oct 27, 2026, 3:54 PM AEDT
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 284.13 million as of October 27, 2026. It is the 20,737th most valuable company in the world and the 394th biggest in Australia. Its market cap has increased by 25.45% in one year.
Market Cap
284.13M
Enterprise Value
260.73M
Revenue
3.86M
Global Rank
Country Rank
#394 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 284.13M, an increase of 86.92%. That is a compound annual growth rate of 60.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 284.13M | 72.11% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 585.74M |
| Clinuvel Pharmaceuticals | 359.05M |
| Racura Oncology | 310.77M |
| Starpharma Holdings | 223.08M |
| BLS Pharmaceuticals | 215.33M |
| Actinogen Medical | 177.00M |
| Paradigm Biopharmaceuticals | 146.80M |
| Orthocell | 140.28M |